Alteration of prognostic efficacy of albumin‐bilirubin grade and Child‐Pugh score according to liver fibrosis in hepatocellular carcinoma patients with Child‐Pugh A following hepatectomy

Abstract Background The albumin‐bilirubin (ALBI) grade was developed to predict the prognosis of patients with hepatocellular carcinoma (HCC), which can stratify the prognosis even in HCC patients with Child‐Pugh A. We evaluated the prognostic efficacy of the ALBI grade and Child‐Pugh classification...

Full description

Bibliographic Details
Main Authors: Tatsunori Miyata, Yo‐ichi Yamashita, Kota Arima, Takaaki Higashi, Hiromitsu Hayashi, Katsunori Imai, Hidetoshi Nitta, Akira Chikamoto, Toru Beppu, Hideo Baba
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Annals of Gastroenterological Surgery
Subjects:
Online Access:https://doi.org/10.1002/ags3.12498
_version_ 1818952559709126656
author Tatsunori Miyata
Yo‐ichi Yamashita
Kota Arima
Takaaki Higashi
Hiromitsu Hayashi
Katsunori Imai
Hidetoshi Nitta
Akira Chikamoto
Toru Beppu
Hideo Baba
author_facet Tatsunori Miyata
Yo‐ichi Yamashita
Kota Arima
Takaaki Higashi
Hiromitsu Hayashi
Katsunori Imai
Hidetoshi Nitta
Akira Chikamoto
Toru Beppu
Hideo Baba
author_sort Tatsunori Miyata
collection DOAJ
description Abstract Background The albumin‐bilirubin (ALBI) grade was developed to predict the prognosis of patients with hepatocellular carcinoma (HCC), which can stratify the prognosis even in HCC patients with Child‐Pugh A. We evaluated the prognostic efficacy of the ALBI grade and Child‐Pugh classification in HCC patients with Child‐Pugh A stratified by the presence or absence of advanced fibrosis or a preoperative biomarker for advanced fibrosis. Methods We retrospectively analyzed 490 consecutive HCC patients with Child‐Pugh A who underwent initial hepatectomies. The accuracy of prognostic prediction using both models was compared by the presence or absence of advanced fibrosis (F3‐4) and its predictor, the preoperative platelet count (PLT). Results The prognostic accuracy of the ALBI grade was better in patients without advanced fibrosis (F3‐4; likelihood ratio: 4.39, corrected Akaike information criterion [AICc]: 453.0, P = .074), but Child‐Pugh score was better in the advanced fibrosis group (likelihood ratio: 10.67, AICc: 915.2, P = .0014). In the high PLT group (≥140 × 103/μL), the prognostic accuracy using the ALBI grade was better in overall survival (OS) and relapse‐free survival (RFS), but in the low PLT group, the Child‐Pugh score was the more accurate model in OS and RFS. Conclusions Depending on the degree of fibrosis or preoperative PLT, the ALBI grade and Child‐Pugh score may provide more accurate prognoses after initial hepatectomy in HCC patients with Child‐Pugh A.
first_indexed 2024-12-20T09:52:18Z
format Article
id doaj.art-d460b3fec0834a93832e0aa72483a38b
institution Directory Open Access Journal
issn 2475-0328
language English
last_indexed 2024-12-20T09:52:18Z
publishDate 2022-01-01
publisher Wiley
record_format Article
series Annals of Gastroenterological Surgery
spelling doaj.art-d460b3fec0834a93832e0aa72483a38b2022-12-21T19:44:33ZengWileyAnnals of Gastroenterological Surgery2475-03282022-01-016112713410.1002/ags3.12498Alteration of prognostic efficacy of albumin‐bilirubin grade and Child‐Pugh score according to liver fibrosis in hepatocellular carcinoma patients with Child‐Pugh A following hepatectomyTatsunori Miyata0Yo‐ichi Yamashita1Kota Arima2Takaaki Higashi3Hiromitsu Hayashi4Katsunori Imai5Hidetoshi Nitta6Akira Chikamoto7Toru Beppu8Hideo Baba9Department of Gastroenterological Surgery Graduate School of Life Sciences Kumamoto University Kumamoto JapanDepartment of Gastroenterological Surgery Graduate School of Life Sciences Kumamoto University Kumamoto JapanDepartment of Gastroenterological Surgery Graduate School of Life Sciences Kumamoto University Kumamoto JapanDepartment of Gastroenterological Surgery Graduate School of Life Sciences Kumamoto University Kumamoto JapanDepartment of Gastroenterological Surgery Graduate School of Life Sciences Kumamoto University Kumamoto JapanDepartment of Gastroenterological Surgery Graduate School of Life Sciences Kumamoto University Kumamoto JapanDepartment of Surgery Saiseikai Kumamoto Hospital Kumamoto JapanDepartment of Gastroenterological Surgery Graduate School of Life Sciences Kumamoto University Kumamoto JapanDepartment of Gastroenterological Surgery Graduate School of Life Sciences Kumamoto University Kumamoto JapanDepartment of Gastroenterological Surgery Graduate School of Life Sciences Kumamoto University Kumamoto JapanAbstract Background The albumin‐bilirubin (ALBI) grade was developed to predict the prognosis of patients with hepatocellular carcinoma (HCC), which can stratify the prognosis even in HCC patients with Child‐Pugh A. We evaluated the prognostic efficacy of the ALBI grade and Child‐Pugh classification in HCC patients with Child‐Pugh A stratified by the presence or absence of advanced fibrosis or a preoperative biomarker for advanced fibrosis. Methods We retrospectively analyzed 490 consecutive HCC patients with Child‐Pugh A who underwent initial hepatectomies. The accuracy of prognostic prediction using both models was compared by the presence or absence of advanced fibrosis (F3‐4) and its predictor, the preoperative platelet count (PLT). Results The prognostic accuracy of the ALBI grade was better in patients without advanced fibrosis (F3‐4; likelihood ratio: 4.39, corrected Akaike information criterion [AICc]: 453.0, P = .074), but Child‐Pugh score was better in the advanced fibrosis group (likelihood ratio: 10.67, AICc: 915.2, P = .0014). In the high PLT group (≥140 × 103/μL), the prognostic accuracy using the ALBI grade was better in overall survival (OS) and relapse‐free survival (RFS), but in the low PLT group, the Child‐Pugh score was the more accurate model in OS and RFS. Conclusions Depending on the degree of fibrosis or preoperative PLT, the ALBI grade and Child‐Pugh score may provide more accurate prognoses after initial hepatectomy in HCC patients with Child‐Pugh A.https://doi.org/10.1002/ags3.12498advanced fibrosisChild‐Pugh scoreHCCprognosisThe ALBI grade
spellingShingle Tatsunori Miyata
Yo‐ichi Yamashita
Kota Arima
Takaaki Higashi
Hiromitsu Hayashi
Katsunori Imai
Hidetoshi Nitta
Akira Chikamoto
Toru Beppu
Hideo Baba
Alteration of prognostic efficacy of albumin‐bilirubin grade and Child‐Pugh score according to liver fibrosis in hepatocellular carcinoma patients with Child‐Pugh A following hepatectomy
Annals of Gastroenterological Surgery
advanced fibrosis
Child‐Pugh score
HCC
prognosis
The ALBI grade
title Alteration of prognostic efficacy of albumin‐bilirubin grade and Child‐Pugh score according to liver fibrosis in hepatocellular carcinoma patients with Child‐Pugh A following hepatectomy
title_full Alteration of prognostic efficacy of albumin‐bilirubin grade and Child‐Pugh score according to liver fibrosis in hepatocellular carcinoma patients with Child‐Pugh A following hepatectomy
title_fullStr Alteration of prognostic efficacy of albumin‐bilirubin grade and Child‐Pugh score according to liver fibrosis in hepatocellular carcinoma patients with Child‐Pugh A following hepatectomy
title_full_unstemmed Alteration of prognostic efficacy of albumin‐bilirubin grade and Child‐Pugh score according to liver fibrosis in hepatocellular carcinoma patients with Child‐Pugh A following hepatectomy
title_short Alteration of prognostic efficacy of albumin‐bilirubin grade and Child‐Pugh score according to liver fibrosis in hepatocellular carcinoma patients with Child‐Pugh A following hepatectomy
title_sort alteration of prognostic efficacy of albumin bilirubin grade and child pugh score according to liver fibrosis in hepatocellular carcinoma patients with child pugh a following hepatectomy
topic advanced fibrosis
Child‐Pugh score
HCC
prognosis
The ALBI grade
url https://doi.org/10.1002/ags3.12498
work_keys_str_mv AT tatsunorimiyata alterationofprognosticefficacyofalbuminbilirubingradeandchildpughscoreaccordingtoliverfibrosisinhepatocellularcarcinomapatientswithchildpughafollowinghepatectomy
AT yoichiyamashita alterationofprognosticefficacyofalbuminbilirubingradeandchildpughscoreaccordingtoliverfibrosisinhepatocellularcarcinomapatientswithchildpughafollowinghepatectomy
AT kotaarima alterationofprognosticefficacyofalbuminbilirubingradeandchildpughscoreaccordingtoliverfibrosisinhepatocellularcarcinomapatientswithchildpughafollowinghepatectomy
AT takaakihigashi alterationofprognosticefficacyofalbuminbilirubingradeandchildpughscoreaccordingtoliverfibrosisinhepatocellularcarcinomapatientswithchildpughafollowinghepatectomy
AT hiromitsuhayashi alterationofprognosticefficacyofalbuminbilirubingradeandchildpughscoreaccordingtoliverfibrosisinhepatocellularcarcinomapatientswithchildpughafollowinghepatectomy
AT katsunoriimai alterationofprognosticefficacyofalbuminbilirubingradeandchildpughscoreaccordingtoliverfibrosisinhepatocellularcarcinomapatientswithchildpughafollowinghepatectomy
AT hidetoshinitta alterationofprognosticefficacyofalbuminbilirubingradeandchildpughscoreaccordingtoliverfibrosisinhepatocellularcarcinomapatientswithchildpughafollowinghepatectomy
AT akirachikamoto alterationofprognosticefficacyofalbuminbilirubingradeandchildpughscoreaccordingtoliverfibrosisinhepatocellularcarcinomapatientswithchildpughafollowinghepatectomy
AT torubeppu alterationofprognosticefficacyofalbuminbilirubingradeandchildpughscoreaccordingtoliverfibrosisinhepatocellularcarcinomapatientswithchildpughafollowinghepatectomy
AT hideobaba alterationofprognosticefficacyofalbuminbilirubingradeandchildpughscoreaccordingtoliverfibrosisinhepatocellularcarcinomapatientswithchildpughafollowinghepatectomy